|
[1]
|
Pelcovits, A. and Niroula, R. (2013) Acute Myeloid Leukemia: A Review. Rhode Island Medical Journal, 103, 38-40.
|
|
[2]
|
Döhner, H., Weisdorf, D.J. and Bloomfield, C.D. (2015) Acute Myeloid Leukemia. The New England Journal of Medicine, 373, 1136-1152. [Google Scholar] [CrossRef]
|
|
[3]
|
Khoury, J.D., Solary, E., Abla, O., et al. (2022) The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia, 36, 1703-1719. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Solh, M., Yohe, S., Weisdorf, D., et al. (2014) Core-Binding Factor Acute Myeloid Leukemia: Heterogeneity, Monitoring, and Therapy. American Journal of Hematology, 89, 1121-1131. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lachowiez, C.A., Loghavi, S., Kadia, T.M., et al. (2020) Out-comes of Older Patients with NPM1-Mutated AML: Current Treatments and the Promise of Venetoclax-Based Regimens. Blood Advances, 4, 1311-1320. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Shafer, D. and Grant, S. (2016) Update on Rational Tar-geted Therapy in AML. Blood Reviews, 30, 275-283. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Liu, Y., Beyer, A. and Aebersold, R. (2016) On the Dependency of Cellular Protein Levels on MRNA Abundance. Cell, 165, 535-550. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wasinger, V.C., Cordwell, S.J., Cerpa-Poljak, A., et al. (1995) Pro-gress with Gene-Product Mapping of the Mollicutes: Mycoplasma Genitalium. Electrophoresis, 16, 1090-1094. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Pandey, A. and Mann, M. (2000) Proteomics to Study Genes and Genomes. Nature, 405, 837-846. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Domon, B. and Aebersold, R. (2006) Mass Spectrometry and Protein Analysis. Science, 312, 212-217. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Bensimon, A., Heck, A.J.R. and Aebersold, R. (2012) Mass Spec-trometry-Based Proteomics and Network Biology. Annual Review of Biochemistry, 81, 379-405. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Guerrera, I.C. and Kleiner, O. (2005) Application of Mass Spectrometry in Proteomics. Bioscience Reports, 25, 71-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Li, X., Wang, W. and Chen, J. (2017) Recent Progress in Mass Spectrometry Proteomics for Biomedical Research. Science China Life Sciences, 60, 1093-1113. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Washburn, M.P., Wolters, D. and Yates, J.R. (2001) Large-Scale Analysis of the Yeast Proteome by Multidimensional Protein Identification Technology. Nature Biotechnology, 19, 242-247. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lasonder, E., Ishihama, Y., Andersen, J.S., et al. (2002) Analysis of the Plasmodium Falciparum Proteome by High- Accuracy Mass Spectrometry. Nature, 419, 537-542. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Gauss, C., Kalkum, M., Löwe, M., et al. (1999) Analysis of the Mouse Proteome. (I) Brain Proteins: Separation by Two-Dimensional Electrophoresis and Identification by Mass Spectrometry and Genetic Variation. Electrophoresis, 20, 575-600. [Google Scholar] [CrossRef]
|
|
[17]
|
Miyamoto, M., Yoshida, Y., Taguchi, I., et al. (2007) In-Depth Proteomic Profiling of the Normal Human Kidney Glomerulus Using Two-Dimensional Protein Prefractionation in Combination with Liquid Chromatography-Tandem Mass Spectrometry. Journal of Proteome Research, 6, 3680-3690. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Deeb, S.J., D’Souza, R.C.J., Cox, J., et al. (2012) Super-SILAC Allows Classification of Diffuse Large B-Cell Lymphoma Subtypes by Their Protein Expression Profiles. Molecular & Cellular Proteomics, 11, 77-89. [Google Scholar] [CrossRef]
|
|
[19]
|
Rudnick, P.A., Markey, S.P., Roth, J., et al. (2016) A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline. Journal of Proteome Research, 15, 1023-1032. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zhu, X., Liu, X., Cheng, Z., et al. (2016) Quantitative Analysis of Global Proteome and Lysine Acetylome Reveal the Differential Impacts of VPA and SAHA on HL60 Cells. Scientific Reports, 6, Article No. 19926. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Geiger, T., Cox, J., Ostasiewicz, P., et al. (2010) Super-SILAC Mix for Quantitative Proteomics of Human Tumor Tissue. Nature Methods, 7, 383-385. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Mund, A., Coscia, F., Kriston, A., et al. (2022) Deep Visual Proteomics Defines Single-Cell Identity and Heterogeneity. Nature Biotechnology, 40, 1231-1240. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Wang, R. and Wang, G. (2019) Protein Modification and Au-tophagy Activation. Advances in Experimental Medicine and Biology, 1206, 237-259. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Liu, Z., Liu, Y., Qian, L., et al. (2021) A Proteomic and Phosphoproteomic Landscape of KRAS Mutant Cancers Identifies Combination Therapies. Molecular Cell, 81, 4076-4090.E8. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Geffen, Y., Anand, S., Akiyama, Y., et al. (2023) Pan-Cancer Analysis of Post-Translational Modifications Reveals Shared Patterns of Protein Regulation. Cell, 186, 3945-3967.E26. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yoshida, Y., Saeki, Y., Murakami, A., et al. (2015) A Comprehensive Method for Detecting Ubiquitinated Substrates Using TR-TUBE. Proceedings of the National Acade-my of Sciences of the United States of America, 112, 4630-4635. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
De Silva, A.R.I. and Page, R.C. (2023) Ubiquitination Detection Techniques. Experimental Biology and Medicine, 248, 1333-1346. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Lin, X., Zhang, H., Boyce, B.F., et al. (2020) Ubiquitination of Interleukin-1α Is Associated with Increased Pro-In- flammatory Polarization of Murine Macrophages Deficient in the E3 Ligase ITCH. The Journal of Biological Chemistry, 295, 11764-11775. [Google Scholar] [CrossRef]
|
|
[29]
|
Ji, F., Zhou, M., Sun, Z., et al. (2021) Integrative Proteomics Re-veals the Role of E3 Ubiquitin Ligase SYVN1 in Hepatocellular Carcinoma Metastasis. Cancer Communications, 41, 1007-1023. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Tibes, R., Qiu, Y., Lu, Y., et al. (2006) Reverse Phase Protein Array: Validation of a Novel Proteomic Technology and Utility for Analysis of Primary Leukemia Specimens and Hem-atopoietic Stem Cells. Molecular Cancer Therapeutics, 5, 2512-2521. [Google Scholar] [CrossRef]
|
|
[31]
|
Dong, H., Ying, T., Li, T., et al. (2006) Comparative Pro-teomic Analysis of Apoptosis Induced by Sodium Selenite in Human Acute Promyelocytic Leukemia NB4 Cells. Journal of Cellular Biochemistry, 98, 1495-1506. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
He, P., Liu, Y., Zhang, M., et al. (2012) Establishment of Two-Dimensional Gel Electrophoresis Profiles of the Human Acute Promyelocytic Leukemia Cell Line NB4. Molecular Medicine Reports, 6, 570-574. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Zada, A.A.P., Geletu, M.H., Pulikkan, J.A., et al. (2006) Proteomic Analysis of Acute Promyelocytic Leukemia: PML- RARα Leads to Decreased Phosphorylation of OP18 at Serine 63. Proteomics, 6, 5705-5719. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Novikova, S., Tolstova, T., Kurbatov, L., et al. (2022) Nuclear Pro-teomics of Induced Leukemia Cell Differentiation. Cells, 11, Article 3221. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Trost, M., Sauvageau, M., Hérault, O., et al. (2012) Posttranslational Regulation of Self-Renewal Capacity: Insights from Proteome and Phosphoproteome Analyses of Stem Cell Leukemia. Blood, 120, e17-e27. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Bertacchini, J., Guida, M., Accordi, B., et al. (2014) Feed-backs and Adaptive Capabilities of the PI3K/Akt/MTOR Axis in Acute Myeloid Leukemia Revealed by Pathway Selec-tive Inhibition and Phosphoproteome Analysis. Leukemia, 28, 2197-2205. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Murray, H.C., Enjeti, A.K., Kahl, R.G.S., et al. (2021) Quantitative Phosphoproteomics Uncovers Synergy between DNA-PK and FLT3 Inhibitors in Acute Myeloid Leukaemia. Leukemia, 35, 1782-1787. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Balkhi, M.Y., Trivedi, A.K., Geletu, M., et al. (2006) Proteomics of Acute Myeloid Leukaemia: Cytogenetic Risk Groups Differ Specifically in Their Proteome, Interactome and Post-Translational Protein Modifications. Oncogene, 25, 7041-7058. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Rithidech, K.N., Honikel, L. and Simon, S.R. (2007) Radiation Leu-kemogenesis: A Proteomic Approach. Experimental Hematology, 35, 117-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Kornblau, S.M., Tibes, R., Qiu, Y.H., et al. (2009) Functional Proteomic Profiling of AML Predicts Response and Survival. Blood, 113, 154-164. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Luczak, M., Kaźmierczak, M., Handschuh, L., et al. (2012) Comparative Proteome Analysis of Acute Myeloid Leukemia with and without Maturation. Journal of Proteomics, 75, 5734-5748. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Habif, G., Grasset, M.F., Kieffer-Jaquinod, S., et al. (2013) Phosphoproteome Analyses Reveal Specific Implications of Hcls1, P21-Activated Kinase 1 and Ezrin in Prolifer-ation of a Myeloid Progenitor Cell Line Downstream of Wild-Type and ITD Mutant Fms-Like Tyrosine Kinase 3 Recep-tors. Journal of Proteomics, 78, 231-244. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Daver, N., Schlenk, R.F., Russell, N.H., et al. (2019) Targeting FLT3 Mutations in AML: Review of Current Knowledge and Evidence. Leukemia, 33, 299-312. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Liang, C.A., Chen, L., Wahed, A., et al. (2019) Proteomics Anal-ysis of FLT3-ITD Mutation in Acute Myeloid Leukemia Using Deep Learning Neural Network. Annals of Clinical and Laboratory Science, 49, 119-126.
|
|
[45]
|
Tashakori, M., Kadia, T., Loghavi, S., et al. (2022) TP53 Copy Number and Protein Expression Inform Mutation Status Across Risk Categories in Acute Myeloid Leukemia. Blood, 140, 58-72. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Jayavelu, A.K., Wolf, S., Buettner, F., et al. (2022) The Proteoge-nomic Subtypes of Acute Myeloid Leukemia. Cancer Cell, 40, 301-317.E12. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Raffel, S., Klimmeck, D., Falcone, M., et al. (2020) Quantitative Proteomics Reveals Specific Metabolic Features of Acute Myeloid Leukemia Stem Cells. Blood, 136, 1507-1519. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Leung, K.K., Nguyen, A., Shi, T., et al. (2019) Multiomics of Aza-citidine-Treated AML Cells Reveals Variable and Convergent Targets That Remodel the Cell-Surface Proteome. Pro-ceedings of the National Academy of Sciences of the United States of America, 116, 695-700. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Kaźmierczak, M., Luczak, M., Lewandowski, K., et al. (2013) Es-terase D and γ 1 Actin Level Might Predict Results of Induction Therapy in Patients with Acute Myeloid Leukemia Without and with Maturation. Medical Oncology, 30, Article No. 725. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Casado, P., Wilkes, E.H., Miraki-Moud, F., et al. (2018) Proteo-mic and Genomic Integration Identifies Kinase and Differentiation Determinants of Kinase Inhibitor Sensitivity in Leuke-mia Cells. Leukemia, 32, 1818-1822. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Bai, J., He, A., Zhang, W., et al. (2013) Potential Biomarkers for Adult Acute Myeloid Leukemia Minimal Residual Disease Assessment Searched by Serum Peptidome Profiling. Prote-ome Science, 11, Article No. 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Van Alphen, C., Cloos, J., Beekhof, R., et al. (2020) Phosphotyro-sine-Based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines. Molecular & Cellular Proteomics, 19, 884-899. [Google Scholar] [CrossRef]
|
|
[53]
|
Frejno, M., Meng, C., Ruprecht, B., et al. (2020) Proteome Ac-tivity Landscapes of Tumor Cell Lines Determine Drug Responses. Nature Communications, 11, Article No. 3639. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Hütter, G., Letsch, A., Nowak, D., et al. (2009) High Correlation of the Proteome Patterns in Bone Marrow and Peripheral Blood Blast Cells in Patients with Acute Myeloid Leukemia. Journal of Translational Medicine, 7, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Zheng, R.J., Wu, R.J. and Ma, X.D. (2017) Serum Proteomic Spectral Characteristics of Acute Myeloid Leukemia and Their Clinical Sig-nificance. Genetics and Molecular Research, 16, gmr16029172. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Tong, J., Helmy, M., Cavalli, F.M.G., et al. (2017) Integrated Analysis of Proteome, Phosphotyrosine-Proteome, Tyrosine-Kinome, and Tyrosine-Phosphatome in Acute Myeloid Leukemia. Proteomics, 17, Article ID: 1600361. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Hu, C.W., Qiu, Y., Ligeralde, A., et al. (2019) A Quantitative Analy-sis of Heterogeneities and Hallmarks in Acute Myelogenous Leukaemia. Nature Biomedical Engineering, 3, 889-901. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Kramer, M.H., Zhang, Q., Sprung, R., et al. (2022) Proteomic and Phosphoproteomic Landscapes of Acute Myeloid Leukemia. Blood, 140, 1533-1548. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Schoof, E.M., Furtwängler, B., Üresin, N., et al. (2021) Quantita-tive Single-Cell Proteomics as a Tool to Characterize Cellular Hierarchies. Nature Communications, 12, Article No. 3341. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Goroshchuk, O., Kolosenko, I., Kunold, E., et al. (2021) Ther-mal Proteome Profiling Identifies PIP4K2A and ZADH2 as Off-Targets of Polo-Like Kinase 1 Inhibitor Volasertib. FASEB Journal, 35, e21741. [Google Scholar] [CrossRef]
|